Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Yersinia type III secretion: send in the effectors.

Guy R Cornelis1

  • 1Biozentrum der Universität Basel, Switzerland. guy.cornelis@unibas.ch

The Journal of Cell Biology
|August 7, 2002
PubMed
Summary

Pathogenic Yersinia bacteria deliver effectors into immune cells, blocking host responses. Studying this mechanism reveals insights into phagocytosis and inflammation processes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000-2017.

Emerging infectious diseases·2018
Same author

Identification of Virulent Capnocytophaga canimorsus Isolates by Capsular Typing.

Journal of clinical microbiology·2017
Same author

Evidence for a LOS and a capsular polysaccharide in Capnocytophaga canimorsus.

Scientific reports·2016
Same author

Correction: The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG.

PLoS pathogens·2015
Same author

Modification of the 1-Phosphate Group during Biosynthesis of Capnocytophaga canimorsus Lipid A.

Infection and immunity·2015
Same author

A bacterial type III secretion-based protein delivery tool for broad applications in cell biology.

The Journal of cell biology·2015

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Pathogenic Yersinia species, including Yersinia pestis, Yersinia pseudotuberculosis, and Yersinia enterocolitica, are known for their ability to cause disease.
  • These bacteria possess sophisticated mechanisms to interact with and manipulate host immune cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which pathogenic Yersinia spp. deliver effector proteins into host immune cells.
  • To understand how these delivered effectors inhibit host signaling cascades and impede the immune response to infection.

Main Methods:

  • Investigating the Yersinia type III secretion system (TSS).
  • Analyzing the translocation of Yersinia effectors into phagocytic cells.
  • Assessing the impact of effectors on host cell signaling pathways.

Main Results:

  • Pathogenic Yersinia species utilize a type III secretion system to inject effector proteins directly into host immune cells.
  • These effectors interfere with critical signaling pathways, such as NF-κB activation, thereby suppressing the inflammatory response.
  • The study provides a detailed molecular understanding of Yersinia's immune evasion strategies.

Conclusions:

  • The Yersinia effector delivery system is a key virulence factor that subverts host immunity.
  • Understanding these molecular mechanisms offers valuable insights into fundamental processes of phagocytosis and inflammation.
  • This knowledge can inform the development of novel therapeutic strategies against Yersinia infections.

Related Experiment Videos